IDT Biologika @ Outsourced Pharma Capacity Update – Cell & Gene Session – October 2024

View the presentation from our Senior Expert Business Development Dr. Nanette Schlatermund about IDT Biologika´s Gene Therapy from Process Development to Commercial Manufacturing

In this webinar you will learn more about:

– Challenges in AAV manufacturing and how we settle them

– Concepts and strategies for Adeno Associated Virus manufacturing, including almost all requested Analytical Services

– How we handle the various entry points for customer projects at IDT Biologika

– Scale-up from process transfer / development to clinical and commercial manufacturing, including our capacities in drug substance and fill-finish manufacturing

<br>